首页> 外文期刊>The Lancet infectious diseases >New developments in the diagnosis of bloodstream infections.
【24h】

New developments in the diagnosis of bloodstream infections.

机译:诊断血流感染的新进展。

获取原文
获取原文并翻译 | 示例
           

摘要

New techniques have emerged for the detection of bacteria in blood, because the blood culture as gold standard is slow and insufficiently sensitive when the patient has previously received antibiotics or in the presence of fastidious organisms. DNA-based techniques, hybridisation probes, and PCR-based detection or protein-based detection by mass spectroscopy are aimed at rapid identification of bacteria and provide results within 2 h after the first signal of growth in conventional blood cultures. Also, detection of microorganisms directly in blood by pathogen-specific or broad-range PCR assays (eubacterial or panfungal) shows promising results. Interpretation is complex, however, because of detection of DNA rather than living pathogens, the risk of interfering contamination, the presence of background DNA in blood, and the lack of a gold standard. As these techniques are emerging, clinical value and cost-effectiveness have to be assessed. Nevertheless, molecular assays are expected eventually to replace the current conventional microbiological techniques for detection of bloodstream infections.
机译:已经出现了用于检测血液中细菌的新技术,因为当患者先前已接受抗生素或在有挑剔生物的情况下,作为金标准的血液培养速度缓慢且灵敏度不足。基于DNA的技术,杂交探针以及基于质谱的基于PCR的检测或基于蛋白质的检测旨在快速鉴定细菌,并在常规血液培养中第一个生长信号后2小时内提供结果。同样,通过病原体特异性或大范围PCR检测(真细菌或泛真菌)直接检测血液中的微生物也显示出令人鼓舞的结果。但是,解释很复杂,因为检测到的是DNA而不是活的病原体,存在干扰污染的风险,血液中存在背景DNA以及缺乏金标准。随着这些技术的兴起,必须评估临床价值和成本效益。然而,分子测定有望最终取代当前用于检测血流感染的常规微生物技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号